Supplementation with glycoursodeoxycholic acid (GUDCA) can come to inhibit the intestinal FXR axis, which can reduce blood ceramide levels and thus reduce atherosclerosis in ApoE-/- model mice on a high cholesterol diet20. Here, NR1H4 is linked to atherosclerosis.